Rezultati

eNauka >  Results >  Nintedanib plus pemetrexed versus placebo plus pemetrexed in patients with relapsed or refractory, advanced non-small cell lung cancer (LUME-Lung 2): A randomized, double-blind, phase III trial
Title: Nintedanib plus pemetrexed versus placebo plus pemetrexed in patients with relapsed or refractory, advanced non-small cell lung cancer (LUME-Lung 2): A randomized, double-blind, phase III trial
Authors: Hanna, Nasser H; Kaiser, Rolf; Sullivan, Richard N; Aren, Osvaldo Rudy; Ahn, Myung-Ju; Tiangco, Beatrice; Voccia, Isabelle; von, Pawel Joachim; Kovcin, Vladimir N; Agulnik, Jason;
Gaschler-Markefski, Birgit; Barrueco, Jose; Sikken, Patricia; Schloss, Charles; Kim, Joo-Hang;
Issue Date: 2016
Publication: LUNG CANCER
ISSN: 0169-5002 Lung Cancer Search Idenfier
Type: Article
Collation: vol. 102 str. 65-73
DOI: 10.1016/j.lungcan.2016.10.011
WoS-ID: 000392565100012
Scopus-ID: 2-s2.0-84994609086
URI: https://enauka.gov.rs/handle/123456789/820495
Project: Boehringer Ingelheim
Metadata source: (Preuzeto iz Nasi u WoS)
M-category: 
21M21

90
SCOPUSTM
61
OpenCitations
82
WEB OF SCIENCETM
Alt metrika
Dimensions
Unpaywall

Rezultati na eNauka su zaštićeni autorskim pravima i sva prava su zadržana, osim ako nije drugačije naznačeno.